Our Products

Medsource Ozone Biomedicals Pvt. Ltd.

One of the largest IVD manufacturers, we are setting the standards in medical diagnostics since 2003.

Read More
0+ Customers

Being Regularly Served

0+ Team Members

Across R&D, Production, Sales, Service, Admin & Support

0+ Distribution Partners

Across 45 countries around the world

R & D

As a primary manufacturer, our ISO 13485 compliant manufacturing facility is also the hub for research and development activities. The research activities typically focus upon:

  • New Product Development
  • Product Improvement
  • Contract Research
  • Process Improvement
  • Cost Optimization

If you would like to work with us on a specific project for product development or improvement, please do write to us.

OEM Opportunities

Having invested significantly in terms of product development, optimization and capacity enhancement, we recognize OEM business as an important aspect for our medium term strategy. We offer our products in various formats including unlabeled goods, bulk reagents, semi finished goods, branded OEM specific design kits, processed raw materials etc.

OEM partners are carefully chosen and handled by a dedicated team delinked to our main business development team. Typically our OEM partners have a long term view of the partnership and complement our business activities. Excellent support system and guidance mechanisms are offered to support our OEM partner's requirements. If you would like to consider an OEM partnership with us, please write to us at mail@ozonebio.com clearly indicating your interest in OEM business activities.

Latest News

Explore All News
A new journey of growth with our Series A fund raise
Leading In Vitro Diagnostics (IVD) manufacturer Medsource Ozone Biomedicals Pvt. Ltd. has raised an undisclosed amount from private equity firm Xponentia Capital Partners.
 
Medsource Ozone Biomedicals is one of the largest Indian manufacturers of IVD products supplying specialized products to labs pan-India as well exporting to over 35+ countries. Its key products include testing instruments, rapid test kits and reagents for conducting several kinds of diagnostic tests by laboratories. It was also one of the few suppliers of Covid RT-PCR related kits to Indian laboratories. Recently, the company has launched a D2C brand Ozocheck where it sells personal use medical devices through online and offline channels. 

Medsource has been growing year-on-year at a fast pace and aims to use the funds to launch new products and expand its distribution in India and overseas markets. The company will shortly commission its new state of the art manufacturing facility which will help double its capacity. The management also plans to grow through acquisitions and/or partnerships in adjacent product segments.

Mr.Ajaykumar Bhatt, CEO of Medsource Ozone commented: “We are thrilled to partner with Xponentia as they join us in our growth journey. We are confident that together we will set new standards for IVD industry and execute an inclusive growth plan which benefits our customers, team members, shareholders and most importantly, the patients."

Commenting on the investment, Xponentia Capital Partners Founder and Managing Partner Devinjit Singh said, “We are delighted to partner Medsource Ozone in its journey towards building the leading company in the IVD industry with new and innovative testing solutions for diagnostic laboratories. The Indian diagnostics industry is at an inflexion point given the increasing awareness and focus on preventive healthcare. With its professional management team, R&D capabilities and market reputation, Medsource Ozone is well placed to build on its competencies towards building a world class organization.”

Lymonds Mirus Capital Advisors, led by its partner Rashmi Bajaj was the exclusive advisor to the transaction.
Careers @ Medsource

Join the team committed to providing extraordinary solutions to its customers 

Apply Now Know More

Insights

View All

Rapid Detection Of Cardiac Troponin To Help Diagnose Myocardial Infarction

Imagine you are a physician or a paramedic called to an emergency. The patient presents with acute chest pain, shortness ...

Read more -

ANA ELISA Vs Indirect Immunofluorescence: Do We Have A Final Verdict?

By Sankalp Kulshrestha, Product Specialist (Autoimmune Diagnostics) with inputs from Prateek Mittal, Marketing Manager September 2014 Anti Nuclear Antibodies (ANA) are ...

Read more -
Copyright - All Rights Reserved - Medsource Ozone Biomedicals Pvt. Ltd. Powered by ITPL